Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice Experiment

ConclusionPatient preferences for antithrombotic treatments were unaffected by disease stage but varied by bleeding risk and other factors. This heterogeneity in preferences is an important consideration because it can affect the benefit –risk balance and the acceptability of antithrombotic treatments to patients.
Source: The Patient - Patient-Centered Outcomes Research - Category: International Medicine & Public Health Source Type: research